Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Dienogest
Stragen Nordic A/S
G03DB; G03DB08
Dienogest
2 milligram(s)
Film-coated tablet
Pregnadien derivatives; dienogest
2019-06-28
1 06660 PACKAGE LEAFLET: INFORMATION FOR THE USER DIENOGEST STRAGEN 2 MG FILM-COATED TABLETS Dienogest READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See Section 4. WHAT IS IN THIS LEAFLET : 1. What Dienogest Stragen is and what it is used for 2. What you need to know before you take Dienogest Stragen 3. How to take Dienogest Stragen 4. Possible side effects 5. How to store Dienogest Stragen 6. Contents of the pack and other information 1. WHAT DIENOGEST STRAGEN IS AND WHAT IT IS USED FOR Dienogest Stragen is a medicine used for the treatment of endometriosis (painful symptoms due to displaced tissue of the lining of the womb). Dienogest Stragen contains a hormone, the progestogen Dienogest Stragen. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DIENOGEST STRAGEN DO NOT TAKE DIENOGEST STRAGEN IF YOU : are suffering from a BLOOD CLOT (thromboembolic disorder) in your veins. This may occur, for example, in the blood vessels of the legs (deep vein thrombosis) or the lungs (pulmonary embolism). See also _“Dienogest Stragen and venous blood clots” _below; have or have ever had a SEVERE ARTERIAL DISEASE, including cardiovascular disease, such as a HEART ATTACK, STROKE or HEART DISEASE which causes a reduced blood supply (angina pectoris). See also _"Dienogest Stragen and arterial blood clots" _below; have DIABETES with blood vessel damage; have or have ever had SEVERE LIVER DISEASE (and your liver function values have not returned to normal); Symptoms of liver disease may be yellowing of the skin and/or itching of the Read the complete document
Health△Products△Regulatory△Authority 04△July△2019 CRN008LN4 Page△1△of△10 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dienogest△Stragen△2△mg△film-coated△tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each△tablet△contains△2△mg△dienogest For△the△full△list△of△excipients,△see△section△6.1. 3 PHARMACEUTICAL FORM Film-coated△Tablets White,△round,△7.1△mm△wide△and△3.4△mm△high 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment△of△endometriosis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Posology_ The△dosage△of△Dienogest△Stragen△is△one△tablet△daily△without△any△break,△taken△preferably△at△the△same△time△each△day△with△some△ liquid△as△needed.△The△tablet△can△be△taken△with△or△without△food. Tablets△must△be△taken△continuously△without△regard△to△vaginal△bleeding.△When△a△pack△is△finished△the△next△one△should△be△started without△interruption. There△is△no△experience△with△Dienogest△Stragen△treatment >△15△months△in△patients△with△endometriosis.△Treatment△can△be△ started△on△any△day△of△the△menstrual△cycle. Any△hormonal△contraception△needs△to△be△stopped△prior△to△initiation△of△Dienogest△Stragen.△If△contraception△is△required,△ non-hormonal△methods△of△contraception△should△be△used△(e.g.△barrier△method). _Management of missed tablets:_ The△efficacy△of△Dienogest△Stragen△may△be△reduced△in△the△event△of△missed△tablets,△vomiting△and/or△diarrhea△(if△occurring△within△ 3-4△hours△after△tablet△taking).△In△the△event△of△one△or△more△missed△tablets,△the△woman△should△take△one△tablet△only,△as△soon△as△ she△remembers,△and△should△then△continue△the△next△day△at△her△usual△time.△A△tablet△not△absorbed△due△to△vomiting△or△diarrhea△ sh Read the complete document